
Homeopathy is one of the most controversial subjects within the healthcare system and NHS England has outlined its stance by …
Specialist medical education company, Wave, has boosted its editorial and programme delivery teams with two new appointments. Sadaf Kazi joins …

The British Pharmacopoeia (BP) 2018 is now published and available for purchase. An essential text for anyone working to develop …

New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …

The Central Drugs Standard Control Organisation (CDSCO) tested drugs to determine whether they were of standard quality but found that …

Teva, one of the world’s biggest generics firms and the biggest company in Israel, has revealed it plans to slash …

Mitsubishi Tanabe Pharma Corporation (MTPC) has announced that it has moved to acquire Israeli pharma company, NeuroDerm, in a deal …

GSK continue its appointment spree with a particularly notable staff acquisition, with leading immuno-oncology scientist, Dr Laurie Glimcher, joining its …

The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …

McKinsey & Company discuss how pharma company executives need to seize every opportunity to embed productivity in their thinking and …

In a press conference at the White House, President Trump, alongside representatives from Corning, MSD and Pfizer, announced that 1,000 …

Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …

MSD, known as Merck in North America, has been granted approval for its biosimilar of Sanofi’s diabetes treatment, Lantus. Potentially, …

A blood test has been created that could offer an inexpensive, and less invasive, alternative to current Alzheimer’s disease tests. …

The European Commission has announced that it has decided to approve Leo Pharma’s Kyntheum (brodalumab), making it the first and …